Search - tctmd.com

Displaying 301 - 320 of 371

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Jason Kahn

January 02, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

News Daily News

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Yael L. Maxwell

December 05, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

November 20, 2012

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

Presentation TCT 2012

Should the Presence of Diabetes Affect Decisions on PCI vs. CABG, and Which DES to Choose?

Presenter: Duk-Woo Park

October 22, 2012

Presentation TCT 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presenter: Masato Nakamura

October 22, 2012

News Daily News

Un Registro Confirma Supervivencia a Largo Plazo de las Mujeres tras la Implantación de un Stent

Yael L. Maxwell

October 05, 2012

News Daily News

Registry Confirms Long-Term Survival Higher in Women After Stenting

Yael L. Maxwell

October 05, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Daily News

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

L.A. McKeown

July 30, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

El Xience V No es Inferior al Cypher en PCI Primarias

July 24, 2012

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

Advertisement

TCTMD’s Top 10 Most Popular News Stories for 2012

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Should the Presence of Diabetes Affect Decisions on PCI vs. CABG, and Which DES to Choose?

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Un Registro Confirma Supervivencia a Largo Plazo de las Mujeres tras la Implantación de un Stent

Registry Confirms Long-Term Survival Higher in Women After Stenting

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Xience V Noninferior to Cypher for Primary PCI

El Xience V No es Inferior al Cypher en PCI Primarias

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content